🇺🇸 FDA

Intelligence · Patent portfolio

Tonix Pharmaceuticals Holding Patents

Full USPTO pharma patent portfolio for Tonix Pharmaceuticals Holding — grant dates, expiration, and drug cross-links.

Patents
86
Expiring ≤24m
2

Quick answer

Tonix Pharmaceuticals Holding has 86 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 2

  1. US 12383733

    Iontophoresis-based patch type medicine absorption device

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12365879

    Synthetic chimeric poxviruses

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12304901

    Selective ligands for tau aggregates

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12156897

    Magnesium-containing oxytocin formulations and methods of use

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12156864

    Analogs of cyclobenzaprine and amitryptilene

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12097183

    Pharmaceutical composition for treating migraine

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12090139

    Formulations comprising triptan compounds

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11998516

    Methods and compositions for treating depression using cyclobenzaprine

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11975161

    Drug releasing coatings for balloon catheters

    Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11970554

    Labeled oxytocin and method of manufacture and use

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11839594

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11826321

    Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11737991

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11566032

    Radio-protective and chemo-protective substituted thiols

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11534430

    Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs

    Expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11517557

    Analogs of cyclobenzaprine and amitriptyline

    Expires Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11389473

    Magnesium-containing oxytocin formulations and methods of use

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11376404

    Drug releasing coatings for medical devices

    Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11026898

    Eutectic formulations of cyclobenzaprine hydrochloride

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10994055

    Drug releasing coatings for medical devices

    Expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10946027

    Tianeptine oxalate salts and polymorphs

    Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10912931

    Drug releasing coatings for balloon catheters

    Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10912932

    Drug releasing coatings for balloon catheters

    Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10881644

    Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs

    Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10864176

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10864175

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10835719

    Drug releasing coatings for medical devices

    Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10736859

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10722478

    Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10485959

    Drug releasing coatings for balloon catheters

    Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10485958

    Drug releasing coatings for balloon catheters

    Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10449203

    Tianeptine oxalate salts and polymorphs

    Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10357465

    Eutectic formulations of cyclobenzaprine hydrochloride

    Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10322094

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10117936

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9956188

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9937159

    Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs

    Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9918948

    Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine

    Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9764065

    Drug releasing coatings for medical devices

    Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9757544

    Drug releasing coatings for medical devices

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9757351

    Medical device rapid drug releasing coatings comprising oils, fatty acids and/or lipids

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9737691

    Drug releasing coatings for balloon catheters

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9737640

    Drug releasing coatings for medical devices

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9700704

    Drug releasing coatings for balloon catheters

    Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9694111

    Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent

    Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9636408

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9474728

    Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine

    Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9402935

    Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs

    Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Tonix Pharmaceuticals Holding have?

86 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Tonix Pharmaceuticals Holding patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.